Moberg Pharma
8.97 SEK
-0.39 %
Less than 1K followers
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.39 %
-15.30 %
-0.33 %
0.00 %
-11.80 %
-42.83 %
-44.05 %
-75.28 %
-84.99 %
Moberg Pharma is a Swedish pharmaceutical company with a focus on commercialization of proprietary drugs based on proven substances. The company works primarily in nail fungus, where Moberg Pharma is developing a topical treatment. Moberg Pharma has agreements with commercial partners in place in Europe and Canada, among other places. The company's headquarters are located in Bromma.
Read moreMarket cap
436.95M SEK
Turnover
481.34K SEK
Revenue
9.81M
EBIT %
-3,311.21 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.2
2026
Annual report '25
12.5
2026
Interim report Q1'26
21.5
2026
General meeting '26
All
Press releases
ShowingAll content types
Moberg Pharma interim report January - September 2025
Moberg Pharma and Karo Healthcare enter exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools